Letter in Response to the Recently Published Review: Hyponatremia in Cirrhosis and End-Stage Liver Disease-Treatment with the Vasopressin V2-Receptor Antagonist Tolvaptan.

Authors :: Abhyankar, A.
Robson, S.
Tapper, E.
Bonder, A.
Source :: Digestive Diseases & Sciences. Mar2013, Vol. 58 Issue 3, p889-890. 2p.
Publication Year :: 2013

Subjects :: *LETTERS to the editor
*HYPONATREMIA
*CIRRHOSIS of the liver
*LIVER disease treatment
*VASOPRESSIN
*G protein coupled receptors
*SODIUM metabolism disorders

Full Text Access

Tools